Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

$599
Posted in: DPP-IVi, Dual/triple agonist, Other, SGLT2i Jul 30 | 2021Lexicon, Merck, and Intercept Q2 '21 Earnings UpdatePurchase Blast
dexcom cover image
$599
Posted in: Glucose Monitoring Jul 29 | 2021Dexcom Q2 '21 Earnings UpdatePurchase Blast
astrazeneca cover image
$599
Posted in: Other, SGLT2i Jul 29 | 2021AZ Q2 '21 Earnings UpdatesPurchase Blast
news cover image
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Jul 22 | 2021Abbott, Roche, and Adocia Q2 '21 Earnings UpdatesPurchase Blast
european medicines agency cover image
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Other, SGLT2i Jul 19 | 2021Removal of Forxiga T1DM Indication? Generic Sitagliptin Up for Opinion?; July 19-22 CHMP AgendaPurchase Blast
1 2 3 58

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.